Stephen Mayo - Aug 7, 2023 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role: Director
Signature: /s/Lillian Smith, Attorney-in-Fact
Stock symbol: ALLO
Transactions as of: Aug 7, 2023
Transactions value $: -$42,855
Form type: 4
Date filed: 8/9/2023, 04:07 PM
Previous filing: Jun 15, 2023
Next filing: Mar 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALLO	Common Stock	Sale	-$42.9K	-10K	-28.31%	$4.29	25.3K	Aug 7, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.27 to $4.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.27 to $4.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.